FDA NDC Directory · JSON-LD · Markdown

CINVANTI

NDC 47426-201 · HUMAN PRESCRIPTION DRUG · INJECTION, EMULSION

Generic nameaprepitant
Labeler / ManufacturerHeron Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA209296
Dosage form / routeINJECTION, EMULSION · INTRAVENOUS
Active ingredientsAPREPITANT (130 mg/18mL)
Marketing started20180103
Package count1

External sources

Source: openFDA. Public-domain (CC0).